Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$964K Buy
3,428
+178
+5% +$44.8K 0.1% 127
2026
Q1
$788K Buy
3,250
+1,604
+97% +$434K 0.09% 128
2025
Q4
$488K Buy
1,646
+39
+2% +$11.7K 0.06% 155
2025
Q3
$453K Buy
1,607
+47
+3% +$12.3K 0.06% 148
2025
Q2
$460K Buy
1,560
+25
+2% +$6.44K 0.07% 137
2025
Q1
$382K Buy
1,535
+12
+0.8% +$2.94K 0.06% 144
2024
Q4
$335K Sell
1,523
-72
-5% -$16K 0.06% 148
2024
Q3
$353K Buy
1,595
+62
+4% +$12.2K 0.06% 143
2024
Q2
$265K Sell
1,533
-33
-2% -$5.73K 0.05% 157
2024
Q1
$299K Sell
1,566
-1
-0.1% -$182 0.06% 155
2023
Q4
$256K Buy
+1,567
New +$237K 0.05% 155

Other funds holding IBM

Embree Financial Group's IBM Position: Q2 2026 in Review

Embree Financial Group increased its IBM (IBM) stake by 5.5% in Q2 2026, buying an estimated $44.8K and bringing the position to 3,428 shares worth $964K. The position accounts for 0.1% of the portfolio, ranked #127.

Embree Financial Group first reported a position in IBM in Q4 2023 and has held it in 11 quarters since. 682 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Embree Financial Group held 3,428 shares of IBM worth $964K as of Q2 2026.
  • Embree Financial Group bought 178 IBM shares in Q2 2026, an estimated $44.8K.
  • IBM made up 0.1% of Embree Financial Group's portfolio in Q2 2026, its #127 holding.
  • Embree Financial Group first reported a position in IBM in Q4 2023 and has held it in 11 quarters since.
  • 682 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.